Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
About the journal
Impact Factor 2.91
Open access to all articles
View the Editorial Board
Tracked/indexed by PubMed, PubMed Central, Medline, Thomson Reuters (ISI), CABI, CAS, EMBASE, Scopus, Zoological Record, Current Contents and Google Scholar
Instructions for authors submitting a manuscript
Contact us
View the most accessed articles
RSS feed of the latest articles
Promote the journal Posters, leaflets, T-Shirts and more.
View answers to some Frequently Asked Questions
Read about authors who have published in Malaria Journal





Editor-in-Chief: Marcel Hommel, University of Liverpool

Malaria Journal is ready to receive manuscripts on all aspects of malaria.

Submit your manuscript online.

Latest articles

Research    
Control of pyrethroid and DDT-resistant Anopheles gambiae by application of indoor residual spraying or mosquito nets treated with a long-lasting organophosphate insecticide, chlorpyrifos-methyl
Raphael N'Guessan, Pelagie Boko, Abibathou Odjo, Joseph Chabi, Martin Akogbeto, Mark Rowland
Malaria Journal 2010, 9:44 (8 February 2010)
[Abstract] [Provisional PDF]

The study indicates that chlorpyrifos methyl outperformed DDT and lambdacyhalothrin. In IRS campaigns, it should provode improved levels of transmission control compared to conventional formulations of DDT or pyrethroids, always assuming that the product is available for such use.



Research    
Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria
Kanungnit Congpuong, Pongwit Bualombai, Vick Banmairuroi, Kesara Na-Bangchang
Malaria Journal 2010, 9:43 (4 February 2010)
[Abstract] [Provisional PDF] [PubMed] [Related articles]

The authors discuss the compliance associated with a three-day AS-MQ regimen following a recent change in the treatment guidelines for uncomplicated falciparum malaria in Thailand. The patient data are supported by whole blood/plasma drug levels. In malaria treatment compliance remains a major factor determining effectiveness.



Case study    
Using the social entrepreneurship approach to generate innovative and sustainable malaria diagnosis interventions in Tanzania: a case study
Lisa K Allen, Erin Hetherington, Mange Manyama, Jennifer M Hatfield, Guido van Marle
Malaria Journal 2010, 9:42 (3 February 2010)
[Abstract] [Provisional PDF] [PubMed] [Related articles]

Original approach aimed at improving malaria diagnostic accuracy in sub-Saharan Africa by enhancing community involvement in a Maasai district



Research    
Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa
Noemie Resseguier, Vanessa Machault, Lenaick Ollivier, Eve Orlandi-Pradines, Gaetan Texier, Bruno Pradines, Jean Gaudart, Alain Buguet, Catherine Tourette-Turgis, Christophe Rogier
Malaria Journal 2010, 9:41 (3 February 2010)
[Abstract] [Provisional PDF] [PubMed] [Related articles]

Interesting paper on the determinants of prophylaxis among French soldiers during missions in Africa.



Research    
Malaria vectors of Timor-Leste
Robert D Cooper, Michael D Edstein, Stephen P Frances, Nigel W Beebe
Malaria Journal 2010, 9:40 (2 February 2010)
[Abstract] [Provisional PDF] [PubMed] [Related articles]

Using molecular analysis a number of issues regarding the anopheline fauna of Timor-Leste were resolved and nine putative species of Anopheles were identified; two species: Anopheles barbirostris and Anopheles vagus genotype B, were incriminated as malaria vectors.



News from SciDev.Net

More news


Plasmodium life-cycle and natural history of malaria



This animation, which illustrates, in six short sequences, the various stages of the life-cycle of the malaria parasite in the human host and in its mosquito vector, has been conceived by Professors Christophe Rogier et Marcel Hommel.

register
Malaria Journal
BioMed Central
PubMed
PubMed Central


 ISSN: 1475-2875

**

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.